DRKS00024808
Completed
Not Applicable
Collection of blood samples for analytical performance evaluation under the IVDR of in vitro test systems in the area of Allergy and Nutrition Care - IVDR-All/NC-01
ConditionsAllergiesFood Intolerance
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- AllergiesFood Intolerance
- Sponsor
- R-Biopharm AG
- Enrollment
- 26
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. ability to understand and willingness to sign a written consent form.
- •2\. females and males 18 years of age or older.
- •3\. Presence of allergy(s) and/or food intolerance(s) (self\-reported).
- •4\. collection of the required volume of whole blood and capillary blood possible.
- •5\. min. 50 kg body weight (in case of allergy).
Exclusion Criteria
- •6\. pregnant and lactating women
- •8\. increased bleeding tendency, or known blood clotting disorder
- •9\. intake of immunosuppressants
- •10\. intake of Omalizumab
- •11\. an event due to which, in the opinion of the principal investigator, the subject is not suitable for participation in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Collection of blood samples for the evaluation of the analytical performance of two new in vitro test systems for tuberculosis diagnosticsA15-A19TuberculosisDRKS00027129R-Biopharm AG636
Recruiting
Not Applicable
Collection of blood samples for research and development of an IP-10 TB-CLIA-AssayA15-A19TuberculosisDRKS00030861R-Biopharm AG200
Active, not recruiting
Not Applicable
Blood collection for the development of a point-of-care troponin platformDiagnosis of myocardial infarctionCirculatory SystemISRCTN13589405Psyros Diagnostics120
Recruiting
Not Applicable
Study of blood and sputum samples of healthy humans and patients for cancer research.Health Condition 1: J988- Other specified respiratory disordersHealth Condition 2: J99- Respiratory disorders in diseasesclassified elsewhereCTRI/2023/01/048765Oxford Cancer Analytics
Completed
Not Applicable
Trial for collection of blood samples from healed Covid-19 patients - research and development of in-vitro diagnosticsSARS-CoV-2 infectionCovid-19U07.1COVID-19, virus identifiedDRKS00022406R-Biopharm AG50